Go to Page # Page of 30

The Comprehensive Type 2 Diabetes Management Algorithm - 2018 Executive Summary

 Alan J. Garber MD PhD, Martin J. Abrahamson MD, Joshua I. Barzilay MD, Lawrence Blonde MD, Zachary T
  14th-Feb-2018
Description: This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience.
Views: 878
Domain: Medical
Category: Therapy
Contributing Organization: AACE
 ‐ More of their Presentations
Maxims of Tech: Rules of Engagement for a Fast Changing Environment
Contents:
AACE/ACE Consensus Statement
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF
CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF
ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES
MANAGEMENT ALGORITHM – 2018 EXECUTIVE SUMMARY
Alan J. Garber, MD, PhD, FACE1; Martin J. Abrahamson, MD2; Joshua I. Barzilay, MD, FACE3;
Lawrence Blonde, MD, FACP, MACE4; Zachary T. Bloomgarden, MD, MACE5; Michael ... See more

Recent Presentations

Clinical Use Of Stem Cells In Orthopaedics

Stem cell research arose from the need to explore new therapeutic possibilities for intractable and lethal diseases. Although musculoskeletal disorders are basically nonlethal, the

...
17 February, 2018
Arnold Evia
16 February, 2018
...
15 February, 2018